<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">767641</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2021.767641</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>N-Acetyl-Cysteine-Loaded Biomimetic Nanofibrous Scaffold for Osteogenesis of Induced-Pluripotent-Stem-Cell-Derived Mesenchymal Stem Cells and Bone Regeneration</article-title>
<alt-title alt-title-type="left-running-head">Li et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Biomimetic Nanofibrous Scaffold Promotes Ostogenesis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiaolei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1452689/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiong</surname>
<given-names>Feng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Shuguang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zhuojun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dai</surname>
<given-names>Jihang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jingcheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Qiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yuan</surname>
<given-names>Huihua</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1354346/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Department of Orthopedics and Orthopedic Institute, Clinical Medical College of Yangzhou University, Subei People&#x2019;s Hospital of Jiangsu Province, <addr-line>Yangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>School of Life Sciences, Nantong University, <addr-line>Nantong</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/713750/overview">Hongbo Zhang</ext-link>, &#xc5;bo Akademi University, Finland</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1466829/overview">Jun Fang</ext-link>, Shanghai Jiao Tong University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1496544/overview">Jingyi Zhu</ext-link>, Nanjing Tech University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Qiang Wang, <email>wangqiangyz@sina.com</email>; Huihua Yuan, <email>yuanhh@ntu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>767641</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Li, Xiong, Wang, Zhang, Dai, Chen, Wang, Wang and Yuan.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Li, Xiong, Wang, Zhang, Dai, Chen, Wang, Wang and Yuan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>To regenerate bone tissues, we investigated the osteogenic differentiation of induced-pluripotent-stem-cell-derived mesenchymal stem cells (iPSC-MSCs) and bone regeneration capacities using N-acetyl cysteine (NAC)-loaded biomimetic nanofibers of hydroxyapatite/silk fibroin (HAp/SF). The addition of HAp and NAC decreased the diameters of the electrospun fibers and enhanced the mechanical properties of the silk scaffold. The release kinetic curve indicated that NAC was released from NAC/HAp/SF nanofibers in a biphasic pattern, with an initial burst release stage and a later sustained release stage. This pattern of release of NAC encapsulated on the NAC/HAp/SF scaffolds prolonged the release of high concentrations of NAC, thereby largely affecting the osteogenic differentiation of iPSC-MSCs and bone regeneration. Thus, a new silk electrospun scaffold was developed. HAp was used as a separate nanocarrier for recharging the NAC concentration, which demonstrated the promising potential for the use of NAC/HAp/SF for bone tissue engineering.</p>
</abstract>
<kwd-group>
<kwd>bone tissue engineering</kwd>
<kwd>n-acetyl cysteine</kwd>
<kwd>HAp/SF nanofibers</kwd>
<kwd>drug release</kwd>
<kwd>osteogenesis</kwd>
</kwd-group>
<contract-sponsor id="cn001">Jiangsu Provincial Medical Youth Talent<named-content content-type="fundref-id">10.13039/501100013059</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Six Talent Peaks Project in Jiangsu Province<named-content content-type="fundref-id">10.13039/501100010014</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">Natural Science Foundation of Jiangsu Province<named-content content-type="fundref-id">10.13039/501100004608</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The combination of a pure bone tissue engineering scaffold and seed cells can repair damaged bone tissue to a certain extent. However, it cannot provide close and effective information connection with surrounding natural organs and tissues to accelerate healing of bone tissue damage. The functional bionics of bone tissue engineering scaffolds are based on this signal factor, one of the three elements of bone tissue engineering (<xref ref-type="bibr" rid="B3">Collignon et&#x20;al., 2017</xref>). Bone tissue can produce growth factors during repair (including bone morphogenetic protein-2 (<xref ref-type="bibr" rid="B9">Groeneveld and Burger, 2000</xref>), insulin-like growth factor (<xref ref-type="bibr" rid="B14">Koch et&#x20;al., 2005</xref>), basic fibroblast growth factor (<xref ref-type="bibr" rid="B4">Du et&#x20;al., 2012</xref>), transforming growth factor-&#x3b2; (<xref ref-type="bibr" rid="B11">Hong et&#x20;al., 2000</xref>), and vascular endothelial growth factor (<xref ref-type="bibr" rid="B15">Mayr-Wohlfart et&#x20;al., 2002</xref>)). Multiple growth factors coordinately control the behavior of bone cells and accelerate the secretion of extracellular matrix in osteoblasts. Bone tissue engineering can also induce osteoblast proliferation and promote bone regeneration after separation and purification of these growth factors.</p>
<p>The most frequently used functional bionics in bone tissue engineering is to select the growth factor that participates in bone repair as a biological activity factor to prepare the bone scaffold and to accelerate bone repair by regulating the rate of release of the growth factor. Functional bionics is also referred to as a third generation of bioactive composite material and biological hybrid material, a compound material, combined with the biological activity of cytokines. It can actively stimulate and induce the self-repair and regeneration of the injured tissue. Thus, damaged tissue and organs can eventually be replaced by healthy tissues or organs (<xref ref-type="bibr" rid="B2">Boccaccini and Blaker, 2005</xref>). Growth factors cannot be widely used in clinics because of the difficulties in extraction, high price, susceptibility to inactivation, short half-life, and immunogenicity to body tissue (<xref ref-type="bibr" rid="B12">James et&#x20;al., 2016</xref>). Small-molecule drugs have good efficacies and stable pesticide effects. They do not easily become inactive during the preparation of scaffolds and have low molecular weights, high solubilities, and diverse structures and functions. They can also be designed and improved according to the requirements and easily produced in large quantities. They attracted considerable attention because of their known molecular structure, low cost, and simple commercialization (<xref ref-type="bibr" rid="B1">Banaszynski et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B17">Ontoria et&#x20;al., 2009</xref>). Accordingly, the use of small-molecule drugs with good properties, instead of growth factors, has become a trend in bone tissue engineering (<xref ref-type="bibr" rid="B21">Xu et&#x20;al., 2008</xref>).</p>
<p>N-acetyl cysteine (NAC), a water-soluble and membrane-permeable small molecule, has various bio-functionalities, including antioxidant activity, ability to improve cytocompatibility, and osteogenic differentiation (<xref ref-type="bibr" rid="B16">Oikawa et&#x20;al., 1999</xref>; <xref ref-type="bibr" rid="B23">Yamada et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B27">Zhu et&#x20;al., 2015</xref>). NAC loaded on a collagen sponge scaffold promotes bone regeneration <italic>in&#x20;vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B23">Yamada et&#x20;al., 2013</xref>). However, NAC is simply absorbed onto this scaffold, which may result in a burst of release of NAC thereby imposing limitations in biological and clinical applications. Therefore, the enhancement of bone regeneration relies on the effective incorporation and viable release of bioactive molecules in a controlled manner over a comparatively long period of bone regeneration. Recently, an NAC-loaded polylactic-co-glycolic acid electrospun system with mesoporous silica nanoparticle nanocarriers was developed for the promotion of osteogenesis of rBMSCs <italic>in&#x20;vitro</italic> (<xref ref-type="bibr" rid="B28">Zhu et&#x20;al., 2019</xref>). Although these systems can achieve controlled delivery of NACs <italic>in&#x20;vitro</italic>, in the clinical settings of bone tissue repair and regeneration, scaffolds as bio-mimetics of the natural bone composition of hydroxyapatite (HAp) and collagen nanofibers are required (<xref ref-type="bibr" rid="B18">Sell et&#x20;al., 2007</xref>). Thus, the fabrication of composite nanofibers consisting of HAp is a rational strategy. HAp-incorporated silk fibroin (HAp/SF) has been considered one of the most attractive biomaterial scaffolding systems for bone tissue engineering (<xref ref-type="bibr" rid="B7">Farokhi et&#x20;al., 2018</xref>).</p>
<p>In this study, HAp/SF composite nanofibers were used as carriers to control the release of NAC and investigate its effect on fiber properties. The effects of HAp/SF composite nanofibers loaded with NAC on the osteogenic differentiation of induced-pluripotent-stem-cell-derived mesenchymal stem cells (iPSC-MSCs) were evaluated at the cellular, protein, and genetic levels. We created a mouse cranial bone defect model and assessed the efficacy of the NAC/HAp/SF nanofibrous scaffold for bone regeneration. This nanofibrous scaffold could maximize the osteogenic ability of iPSC-MSCs in the long term and could be used for personalized and functional bone repair and regeneration applications.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Preparation of NAC/Hydroxyapatite/Silk Fibroin Nanofibers</title>
<p>HAp/SF composite fibers with 10% HAp were selected as drug carriers to prepare drug-loaded fibers with a certain amount of NAC. The blending method was used to disperse NAC evenly in the spinning solution. Drug-loaded fibers were prepared by electrospinning. A solution was prepared by dissolving the required weight of NAC in 10&#xa0;&#x3bc;l of water and adding it to the spinning solution, followed by stirring, and mixing. 0.4&#xa0;g of HAp was added to a stirring bottle containing 2&#xa0;ml of methane acid. The HAp particles were evenly dispersed by ultrasonication for 30&#xa0;min 0.4&#xa0;g of SF and 0.0082&#xa0;g of polyethylene oxide (PEO) were then added to the solution and stirred and dissolved. After stirring for 1 h, 10&#xa0;&#x3bc;L of an aqueous solution containing NAC (0.78&#xa0;mg) was added, and the NAC/HAp/SF solution was then prepared by magnetic stirring for 5&#xa0;h at room temperature. The electrospinning was carried out at a spinning voltage of 7&#x2013;8&#xa0;kV, an injection rate of 0.4&#xa0;ml/h, a receiving distance of 15&#xa0;cm, at room temperature, and an ambient humidity of 30&#x2013;40%.</p>
</sec>
<sec id="s2-2">
<title>Characterization of N-Acetyl Cysteine/Hydroxyapatite/Silk Fibroin Nanofibers</title>
<sec id="s2-2-1">
<title>Morphology of Nanofibers</title>
<p>Morphologies of the different NAC/HAp/SF drug-loaded fiber membranes were observed by scanning electron microscopy (SEM, ZEISS Gemini SEM 300, Germany) and transmission electron microscopy (TEM, Talos F200X, FEI, United&#x20;States). After a double-sided conductive adhesive was attached to the SEM sample stage, the different electrospun fiber membranes (after evaporation of the solvent) were cut into appropriate sizes and attached to the conductive adhesive. The sample was then sprayed with gold for 40&#x20;s under vacuum. Finally, the surface morphology of the electrospun fiber membrane was observed using SEM at an accelerating voltage of 10&#xa0;kV and imaged as needed. The diameter of the fiber was measured using the ImageJ software (at least 50&#x20;times per sample).</p>
</sec>
</sec>
<sec id="s2-3">
<title>Hydrophilic Performance Test</title>
<p>The contact angles of the different drug-loaded fiber membranes were measured using a contact-angle tester (JCY-1, Shanghai Fangrui Instrument Co., Ltd.). 0.3&#xa0;&#x3bc;L of deionized water was dropped on the sample. The morphologies of the water droplets on the fiber membrane at different times were imaged. The angle between the water droplet and fiber membrane was measured to obtain the contact&#x20;angle.</p>
</sec>
<sec id="s2-4">
<title>Test of Drug Release</title>
<p>Ultraviolet spectrophotometry (Thermo Scientific Evolution 300, United&#x20;States) was used to analyze drug release. Scaffold samples (20&#xa0;mg, alcohol gas treated for 1&#xa0;h) were immersed in 2&#xa0;ml of distilled deionized water. The samples were then mixed with a 4-chloro-7-nitrobenzofurazan (0.006&#xa0;wt%) chromogenic agent in a ratio of 1:18. After 30&#xa0;min of reaction, the NAC concentrations were calculated based on the absorbance at 423&#xa0;nm.</p>
</sec>
<sec id="s2-5">
<title>
<italic>In-vitro</italic> Cyto-Compatibility of the N-Acetyl Cysteine /Hydroxyapatite/Silk Fibroin Nanofibers</title>
<p>The rat iPSC-MSCs was induced by the rat iPS cells (Sidansai Biotechnology, Shanghai, China, China) cultured in MSCs medium and consisted of Dulbecco&#x2019;s Modified Eagle&#x2019;s Medium (Hyclone, United&#x20;States), 1% penicillin/streptomycin (Tianjin Haoyang Biological Products Technology Co. Ltd., China), <sc>l</sc>-glutamine (Gibco, United&#x20;States), and 10% fetal bovine serum (Gibco, United&#x20;States). The iPSC-MSCs were cultured at 37&#xb0;C in a 5% CO<sub>2</sub> humidified incubator and the culture medium was changed every 2&#xa0;days.</p>
<p>To prepare nanofiber scaffolds for cell culture, smooth glass sheets (diameter 15&#xa0;mm) were cleaned, sterilized, and placed on an aluminum foil to collect the fibers. After electrospinning of the 2-ml solution, the prepared HAp/SF membranes were dried in a vacuum-drying chamber for at least 5&#xa0;days to remove residual solvents. After the solvent was volatilized, the samples were placed in the corresponding cell-culture plate. Four-to-six samples for each structure were utilized, with blank cover slides placed into a plate as a control group. After 10&#xa0;min of methanol treatment, the SF structure was transformed, methanol was removed, and sample scaffolds were irradiated by ultraviolet light for 2&#xa0;days after methanol volatilization. The samples were soaked in 75% ethanol for 2&#xa0;h, and then washed for 10&#xa0;min with PBS (Phosphate Buffer Saline) three times. Each pore was added to the corresponding cell culture medium. The sample was soaked in an incubator overnight for preculture. The sample was prepared squarely and placed in a cell-culture plate. iPSC-MSCs were planted according to the experimental requirements.</p>
</sec>
<sec id="s2-6">
<title>Effect of Scaffolds on Cell Morphology</title>
<p>Cell spreading on fibers was observed using SEM. To prepare the samples for SEM, the following procedure was used: 1) Cell&#x2013;scaffold complexes were cultured for 1 and 7&#xa0;days and then removed from the culture medium and washed with PBS three times; 2) 4% glutaraldehyde was added to the complexes for a period of 2.5&#xa0;h or longer to immobilize the samples; 3) after the glutaraldehyde was removed, the complexes were washed by PBS three times; 4) samples were washed for 15&#xa0;min in each of six concentrations of alcohol (10, 30, 50, 70, 90, and 100%) for dehydration; 4) treatment with hexamethyldisiloxane was carried out overnight. After drying, the structures were cut into fragments, sprayed with gold, and observed using&#x20;SEM.</p>
</sec>
<sec id="s2-7">
<title>Effects of Scaffolds on Cell Proliferation</title>
<p>The effects of the scaffolds on cell proliferation were evaluated by using cell counting kit-8 (CCK-8). At set times (1, 4, and 7&#xa0;days), an appropriate volume of CCK-8 solution was added to the plates and incubated for 4&#xa0;h. 200&#x20;&#x3bc;l of the culture medium was then extracted and added to a 96-well plate, without bubbles. The absorbance at 450&#xa0;nm was determined using a microplate reader.</p>
</sec>
<sec id="s2-8">
<title>Osteogenic Differentiation of iPSC-MSCs Induced by N-Acetyl Cysteine /HAp/SF Nanofibers <italic>in&#x20;vitro</italic>
</title>
<sec id="s2-8-1">
<title>Quantitative Analysis of Alkaline Phosphatase (ALP)</title>
<p>A BCIP/NBT color development kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) was used to assay ALP activity according to the manufacturer&#x2019;s specifications. A quantitative analysis of ALP was performed using an ALP quantitative kit. The cell supernatant was removed and then 1% Triton X-100 (soluble in PBS) was added and incubated for 30&#xa0;min to split the cells. 30&#x20;ml of the supernatant was distributed among a 96-well plate and then 50&#xa0;&#x3bc;l of the buffer and matrix solution was added and incubated at 37&#xb0;C for 15&#xa0;min 150&#x20;&#x3bc;l of the chromogenic reagent was then added to the 96-well plate, shaken gently, and mixed evenly. The absorbance at 520&#xa0;nm was determined using a microplate reader.</p>
</sec>
<sec id="s2-8-2">
<title>Quantitative Analysis of Collagen (COL)</title>
<p>Quantitative analysis of collagen was performed using a hydroxyproline testing kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) as per the manufacturer&#x2019;s instructions. In summary, the cell supernatant was removed and then 1% Triton X-100 (soluble in PBS) was added and incubated for 30&#xa0;min to lyse the cells. The resulting solution, after lysis, was collected and pH was adjusted to 6.0&#x2013;6.8. Reagent was added according to the hydroxyproline test kit and well mixed, followed by incubation at 60&#x20;&#xb0;C in water for 15&#xa0;min. After cooling and centrifugation for 10&#xa0;min at 3,500&#xa0;rpm, absorbance at 550&#xa0;nm was measured.</p>
</sec>
</sec>
<sec id="s2-9">
<title>Detection of Osteogenesis-Related Genes</title>
<p>After 14&#xa0;days incubation, the expressions of osteogenesis-related genes (ALP, COL, OCN (osteocalcin), and OPN (osteopontin)) in iPSC-MSCs cultured in HAp/SF, 10-NAC/HAp/SF, 20-NAC/HAp/SF nanofiber membranes, and the TCP blank control were detected by reverse transcription polymerase chain reaction (RT-PCR). All primer sequences were listed in <xref ref-type="table" rid="T1">Table&#x20;1</xref>. The procedure for RT-PCR included three principles processes: ribonucleic acid (RNA) extraction, reverse transcription deoxyribonucleic acid (DNA) synthesis, and RT-PCR gene amplification detection. RNA was rapidly extracted using a Biozol RNA extraction kit. Reverse transcription DNA synthesis was undertaken using a 20&#xa0;L reactor containing 20&#x2013;50&#xa0;ng of RNA. RNA was reverse-transcribed to form complementary DNA (cDNA) using the FastQuant RT Kit (with gDNase). RT-PCR was performed using the SuperReal PreMix Plus (SYBR Green) kit, with the housekeeping gene (GAPDH) as a control. After 40 cycles, the relative expression of each target gene was calculated using the 2<sup>&#x2212;&#x394;&#x394;ct</sup> method.</p>
</sec>
<sec id="s2-10">
<title>Bone Regeneration <italic>in vivo</italic>
</title>
<sec id="s2-10-1">
<title>Mouse Cranial Defect Model</title>
<p>After the <italic>in&#x20;vitro</italic> osteogenesis study, we developed a mouse cranial defect model in 6-week-old male Sprague&#x2013;Dawley (SD) rats (Shanghai Slac Laboratory Animal Co. Ltd., Shanghai, China) to analyze the efficacy of the nanofibrous HAp/SF scaffold in bone regeneration. Animal care and use protocols were implemented in accordance with the National Institutes of Health (NIH) Guide. The ethical committee of Yangzhou University approved the experimental procedures. Under general anesthesia, the cranium was exposed through a medial incision. The periosteum overlying the calvarial bone was completely resected. A dental bur was used to create a defect with a diameter of 3&#xa0;mm per mouse. Nanofibrous SF, HAp/SF, NAC/SF, and NAC/HAp/SF scaffolds were implanted in the cranial defects, while the blank group was left untreated. Thirty mice (six in each set) were implanted. The skin was closed with a suture and the defects were analyzed 8&#x20;weeks after implantation.</p>
</sec>
</sec>
<sec id="s2-11">
<title>Computed Tomography (CT) and Bone Mineral Density Analysis</title>
<p>Dual-source CT (SOMATOM Definition, Siemens) was used to detect regeneration and quantify the mineral density of the newly formed bone within the cranial defects. Under general anesthesia, the mouse was fixed and scanned over the entire length at a voxel size of 12&#xa0;l&#xa0;m and medium resolution of 80&#xa0;kVp, 110&#xa0;&#xb5;A with a 0.5-mm Al filter. The regeneration of bone within the defects was visually identified and the manufacturer&#x2019;s evaluation software was used to separate bone from non-bone and the mineral density of the new bone-like tissue was computed and calibrated to a HAp phantom.</p>
</sec>
<sec id="s2-12">
<title>Statistical Analyses</title>
<p>All quantitative values are expressed as mean&#x20;&#xb1; standard error of at least three replicate samples. An analysis of variance for all quantitative tests was carried out with the software Origin and Tukey&#x2019;s honestly significant difference. <italic>Post hoc</italic> tests were used for pair-wise comparisons between groups. Statistical significance was defined by either &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05 or &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c;&#x20;0.01.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Morphology and Physical Properties</title>
<p>Composite fibers were prepared via electrospinning. The morphologies of the different electrospun fibers were observed by SEM (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>) and all fibers exhibited a good morphology. White substances appeared on the surface of the fiber because of the aggregation of Hap. The TEM images showed that HAps were encapsulated within the electrospun silk fibers and the diameter of the fibers decreased with the incorporation of NAC and NAC/HAp, which may increase the conductivity and viscosity of the SF fibers, consistent with the results of <xref ref-type="bibr" rid="B28">Zhu et&#x20;al. (2019)</xref>. Typical tensile stress-strain curves and tensile mechanical properties of composite fiber films are shown in <xref ref-type="fig" rid="F2">Figure&#x20;2</xref>. The addition of HAp, NAC and NAC/HAp had a significant effect on the mechanical properties of SF fibers. The average Young&#x2019;s modulus and tensile strength of SF fibers were 53.76&#x20;&#xb1; 11.67 and 2.54&#x20;&#xb1; 0.30 MPa, respectively. With the addition of HAp, tensile strength and Young&#x2019;s modulus significantly increased. The incorporation of NAC reduced the Young&#x2019;s modulus and the tensile strength to 36.43&#x20;&#xb1; 19.99 MPa and 0.89&#x20;&#xb1; 0.09 MPa, respectively. When NAC/HAp were added, the Young&#x2019;s modulus and the tensile strength increases significantly. The rate of elongation rate decreased with the addition of HAp, NAC and NAC/HAp into SF fibers. Generally speaking, the mechanical properties of the fibers were improved by adding NAC/HAp.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>SEM images of the pure SF, HAp/SF, NAC/SF, and NAC/HAp/SF scaffolds; the insets are corresponding TEM images.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Analysis of tensile properties of the composite fibrous scaffolds including typical stress-strain curves <bold>(A)</bold>, tensile strength <bold>(B)</bold>, modulus <bold>(C)</bold> and elongation <bold>(D)</bold>. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01, <italic>n</italic>&#x20;&#x3d; 5.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Hydrophilic Properties of Fibers</title>
<p>The hydrophilic angles of the composite fiber membranes were measured to evaluate their hydrophilic properties. Contact angles below 90&#xb0; are indicative of hydrophilicity, which favors the diffusion of liquid on the materials. In contrast, contact angles exceeding 90&#xb0; correspond to hydrophobicity (<xref ref-type="bibr" rid="B19">Trinca et&#x20;al., 2017</xref>). The contact angles of NAC/HAp/SF were smaller than those of the other scaffolds (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>). Thus the addition of NAC and HAps decreased the contact angle of the material surface through the synergy between NAC, which contains amine and carboxylic functional groups, and HAps, which contain hydroxyl groups.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Hydrophilic properties of the SF, HAp/SF, NAC/SF, and NAC/HAp/SF composite fiber membranes, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Drug Releasing Patterns of the Fiber-Loading Drug</title>
<p>
<xref ref-type="fig" rid="F4">Figure&#x20;4</xref> shows the cumulative release of NAC per Gram of the composite fiber scaffold. The NAC/SF group exhibited an initial burst of release; NAC then became exhausted after a period of time. In contrast, the release of NAC from the NAC/HAp/SF group exhibited a biphasic pattern, characterized by an initial burst of release followed by a long-term, gradual, and continuous release, during which high NAC concentrations were maintained sufficient to promote cell differentiation. In the first stage, the apparent fast release of NAC drugs may have occurred because some of the small NAC molecules dispersed on the surface of the fiber and the inner layer of the fiber <italic>epidermis</italic> during the electrospinning can be released quickly in the PBS buffer solution (<xref ref-type="bibr" rid="B26">Zheng et&#x20;al., 2013</xref>). In the second stage, NAC inside the composite fiber was gradually released. This indicates that HAp exerted an adsorption effect on NAC and also a significant effect on the drug release behavior of&#x20;NAC.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>NAC release profiles of the NAC/SF and NAC/HAp/SF scaffolds during 0&#x2013;720&#xa0;h in a PBS solution, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Cell Proliferation</title>
<p>The CCK-8 assay was used to detect the proliferation of iPSC-MSCs cultured on composite fiber membranes (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). The cell content in all groups increased with the duration of incubation, which indicates that the cells were in a good state of proliferation. During the process of cell culture, the capacity for cell proliferation of all material groups was higher than that of the coverslip group. Cell proliferation activity was significantly higher in the NAC/SF and NAC/HAp/SF groups than in the control group. This suggests that the addition of NAC and HAps positively affected cell viability.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Proliferation of iPSC-MSCs on different composite fibers and cover slip, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Cell Morphology</title>
<p>The proliferation and spreading of iPSC-MSCs on different composite fibers were further observed by SEM (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>). After 4&#xa0;days of culture, the number of adherent cells in the NAC/HAp/SF group was higher than those in the other groups. After 7&#xa0;days of culture, the number of cells on the fiber increased and the spread of the cells were incorporated with the fiber scaffold. From the perspective of the number of fiber cells, this trend was consistent with the CCK8 results.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Morphological observation of iPSC-MSCs planted on different composite fibers for 4 and 7&#xa0;days, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g006.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Expression of Osteoblast-Related Genes in Cells</title>
<p>To evaluate the capacity for osteogenic differentiation of iPSC-MSCs on different nanofiber scaffolds, the marker genes of osteogenic differentiation (<italic>ALP</italic>, <italic>COL</italic>, <italic>OCN</italic>, and <italic>OPN</italic>) were detected by RT-PCR. After 14&#xa0;days of culture, cells in the corresponding culture plate were collected and RNA was extracted for detection. The SF group was used as a control group in this experiment. The expression of <italic>ALP</italic> in the NAC/HAp/SF fibers increased significantly after 14&#xa0;days (<xref ref-type="fig" rid="F7">Figure&#x20;7</xref>). This may be explained by the fact that as the fibers promote the osteogenic differentiation of iPSC-MSCs and the cell differentiation process is in the middle and late stages, the content of the early expression product of <italic>ALP</italic> gradually decreases. With the addition of HAp and NAC, the expression levels of <italic>COL</italic> and <italic>OCN</italic> were significantly increased (<italic>p</italic>&#x20;&#x3c; 0.01). According to the gene expression level of <italic>OPN</italic>, the addition of HAp increased the level of <italic>OPN</italic> after 14&#xa0;days of cell culture, while the addition of NAC did not affect the expression of <italic>OPN</italic>. The addition of NAC increased not only the level of expression of <italic>ALP</italic>, but also those of <italic>COL</italic> and <italic>OCN</italic>, the marker genes in the middle and late stages of osteogenesis but had no significant effect on the expression of <italic>OPN</italic>. However, compared to the control group, HAp and NAC complemented each other and promoted the expression of <italic>ALP</italic>, <italic>COL</italic>, <italic>OCN</italic>, and <italic>OPN</italic> genes, thus promoting the osteogenic differentiation of iPSC-MSCs.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Expressions of bone-related genes in iPSC-MSCs on different nanofibers for 14&#xa0;days, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g007.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>Expression of ALP in Cells</title>
<p>iPSC-MSCs were planted on different composite fibers. After 14&#xa0;days of culture, ALP staining and quantitative analysis of ALP secreted by cells, including the total amount of ALP and amount of ALP secreted by a single iPSC-MSC, were undertaken. The results are shown in <xref ref-type="fig" rid="F8">Figure&#x20;8</xref>. The addition of HAp resulted in an increase in the expression of ALP in iPSC-MSCs. The addition of NAC also promoted the expression of ALP in iPSC-MSCs, which indicated that it significantly enhanced the osteogenic differentiation of iPSC-MSCs.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>ALP staining. <bold>(A)</bold> and quantitative detection of ALP. <bold>(B)</bold> after iPSC-MSC culture on different composite fibers for 14&#xa0;days, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g008.tif"/>
</fig>
</sec>
<sec id="s3-8">
<title>Expression of COL in Cells</title>
<p>iPSC-MSCs were seeded on composite fibers. After 14&#xa0;days of culture, collagen was quantitatively examined using a testing kit (<xref ref-type="fig" rid="F9">Figure&#x20;9</xref>). The detection results were similar to the results of cellular ALP expression. that is, the loading of NAC promoted not only the expression of total cell COL, but also the expression of COL in a single cell. The total COL expression of all cells and expression of COL in single cells on NAC/HAp/SF fibers were significantly higher than those in the other groups. This indicates that the NAC/HAp/SF composite nanofibers had the highest ability to promote collagen production. Thus, the loading of NAC can effectively improve the osteogenic differentiation performance of the fibers.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Quantitative results of COL after 14&#xa0;days of culture of iPSC-MSCs on different nanofibers, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g009.tif"/>
</fig>
</sec>
<sec id="s3-9">
<title>
<italic>In-vivo</italic> Bone Regeneration</title>
<p>To verify the capability of the biomimetic scaffold of NAC/HAp/SF to regenerate bone <italic>in vivo</italic>, SF, HAp/SF, NAC/SF, and NAC/HAp/SF scaffolds were transplanted into calvarial defects in SD rats. After 8&#xa0;weeks of implantation, CT images demonstrated that the whole defect was almost fully repaired by the formation of bone-like tissues in the NAC/HAp/SF group (<xref ref-type="fig" rid="F10">Figure&#x20;10</xref>). Moreover, the bone mineral density was significantly increased (<italic>p</italic>&#x20;&#x3c; 0.01), peaking at 2.51, 1.18, 1.15, and 1.14&#x20;times those of the blank SF, HAp/SF, NAC/SF, and NAC/HAp/SF groups, respectively (<xref ref-type="fig" rid="F10">Figure&#x20;10F</xref>). Notably, the NAC/HAp/SF scaffold without cells exhibited the highest capacity for repair (<xref ref-type="fig" rid="F10">Figures 10A&#x2013;D</xref>) and highest bone mineral density compared to the other groups (<xref ref-type="fig" rid="F10">Figure&#x20;10F</xref>). The bone mineral density was higher in the NAC/SF group than in the HAp/SF group, but not significantly. The NAC/HAp/SF led to the best outcomes in regenerating cranial bone defects in&#x20;rats.</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>CT examination of the whole calvarias <bold>(A&#x2013;E)</bold> and bone mineral density of the defects <bold>(F)</bold> 8&#xa0;weeks after implantation <italic>in vivo</italic> <bold>(A)</bold> blank, <bold>(B)</bold> SF, <bold>(C)</bold> HAp/SF, <bold>(D)</bold> NAC/SF, and <bold>(E)</bold> NAC/HAp/SF groups. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01, <italic>n</italic>&#x20;&#x3d; 3.</p>
</caption>
<graphic xlink:href="fbioe-09-767641-g010.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Massive bone defects, defined as critical-size bone defects, can cause delayed union and non-union, and even limb dysfunction. There are several origins of massive bone defects, including trauma, bone tumor resection, and revision arthroplasty (<xref ref-type="bibr" rid="B23">Yamada et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B24">Yang et&#x20;al., 2014</xref>).</p>
<p>Numerous small molecules regulate the differentiation and proliferation of various cells (<xref ref-type="bibr" rid="B21">Xu et&#x20;al., 2008</xref>). NAC is a water-soluble compound with a low molecular weight. It has antioxidant properties and enhances cytocompatibility (<xref ref-type="bibr" rid="B25">Zafarullah et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B20">Watanabe et&#x20;al., 2018</xref>). NAC loaded on a collagenous sponge scaffold can promote bone regeneration by accelerating osteogenesis (<xref ref-type="bibr" rid="B23">Yamada et&#x20;al., 2013</xref>).</p>
<p>SF is a natural biopolymer and promising drug carrier owing to its high biocompatibility, tailorable biodegradability, and low bacterial attachment. SF-based scaffolds have been considered potential carriers for drug delivery (<xref ref-type="bibr" rid="B8">Farokhi et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B5">Farokhi et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B6">Farokhi et&#x20;al., 2020</xref>). HAp is widely and clinically used to generate bone tissue because of its high-efficiency osteogenesis (<xref ref-type="bibr" rid="B10">He et&#x20;al., 2012</xref>). Scaffolds have an important role in bone tissue generation, particularly electrospun scaffolds, which have good characteristics for applications in drug delivery and bone repair (<xref ref-type="bibr" rid="B22">Xue et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B13">Ko et&#x20;al., 2018</xref>).</p>
<p>In this study, we developed an HAp/SF scaffold through electrospinning and NAC was loaded onto the HAP/SF scaffold. We analyzed the optimal amount of NAC in the preparation of fibers and evaluated its physical properties, including the morphology, mechanical properties, and hydrophilic properties. The release of NAC in the NAC/HAp/SF compound scaffold exhibited a biphasic pattern characterized by an initial burst in release followed by a long-term, gradual, and continuous release stage to promote cell differentiation due to high NAC concentrations. In addition, HAp was beneficial to the sustained release of the&#x20;drug.</p>
<p>The cell compatibility of the NAC/HAp/SF composite fibers was then evaluated. All drug-loaded fibers were beneficial for cell adhesion, spreading, and proliferation. We detected osteogenic differentiation of iPSC-MSCs. At the protein level (ALP and COL) or gene level (<italic>ALP</italic>, <italic>COL</italic>, <italic>OCN</italic>, and <italic>OPN</italic>), the addition of NAC significantly promoted osteogenic differentiation of iPSC-MSCs. NAC and HAp complemented each other and cooperated to promote the expression of <italic>ALP</italic>, <italic>COL</italic>, <italic>OCN</italic>, and <italic>OPN</italic> genes. The NAC/HAp/SF fiber scaffolds exhibited good biocompatibility and safety and induced osteogenic differentiation of iPSC-MSCs.</p>
<p>To further investigate the capacity for osteogenesis of the NAC/HAp/SF scaffold, we implemented cranial bone defects in rats. After 8 weeks, CT imaging confirmed the capacity of the NAC/HAp/SF scaffolds to repair cranial bone defects. The electrospun nanofibrous NAC/HAp/SF scaffold, with an excellent osteo-induction effect, may be ideal for the regulation of osteogenic differentiation of iPSC-MSCs for patient-specific repair and regeneration of bone tissue in the future.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In this study, we formed NAC/HAp/SF scaffolds by electrospinning and analyzed the release of NAC and their ability to promote cell proliferation and osteogenesis. In addition, we detected osteogenesis in NAC/HAp/SF scaffolds in rats. Although satisfactory results were obtained, shortcomings remain. For example, the period of repair of 8&#x20;weeks in the rat body is short. Furthermore, the exact mechanism of the effect of the NAC/HAp/SF scaffolds on bone generation is unclear. An extended period of observation and evaluation of the exact mechanism of osteogenesis of the NAC/HAp/SF scaffolds should be performed in further studies.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Primer sequences of bone-related genes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Genes</th>
<th align="center">Forward primer sequence (5&#x2032;-3&#x2032;)</th>
<th align="center">Reverse primer sequence (5&#x2032;-3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">OCN</td>
<td align="left">CAG&#x200b;TAA&#x200b;GGT&#x200b;GGT&#x200b;GAA&#x200b;TAG&#x200b;ACT&#x200b;CCG</td>
<td align="left">GGT&#x200b;GCC&#x200b;ATA&#x200b;GAT&#x200b;GCG&#x200b;CTT&#x200b;G</td>
</tr>
<tr>
<td align="left">COL</td>
<td align="left">GGT&#x200b;CCC&#x200b;AAA&#x200b;GGT&#x200b;GCT&#x200b;GAT&#x200b;GG</td>
<td align="left">GAC&#x200b;CAG&#x200b;GCT&#x200b;CAC&#x200b;CAC&#x200b;GGT&#x200b;CT</td>
</tr>
<tr>
<td align="left">ALP</td>
<td align="left">GTC&#x200b;CCA&#x200b;CAA&#x200b;GAG&#x200b;CCC&#x200b;ACA&#x200b;AT</td>
<td align="left">CAA&#x200b;CGG&#x200b;CAG&#x200b;AGC&#x200b;CAG&#x200b;GAA&#x200b;T</td>
</tr>
<tr>
<td align="left">OPN</td>
<td align="left">GCT&#x200b;TCC&#x200b;TGC&#x200b;TCA&#x200b;TCA&#x200b;ATC&#x200b;GTA&#x200b;AC</td>
<td align="left">TCA&#x200b;TCT&#x200b;GCC&#x200b;GAC&#x200b;CCT&#x200b;CTT&#x200b;CT</td>
</tr>
<tr>
<td align="left">GAPDH</td>
<td align="left">GGC&#x200b;AAG&#x200b;TTC&#x200b;AAC&#x200b;GGC&#x200b;ACA&#x200b;GT</td>
<td align="left">GCC&#x200b;AGT&#x200b;AGA&#x200b;CTC&#x200b;CAC&#x200b;GAC&#x200b;AT</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Yangzhou university.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>XL, FX, SW, QW and HY carried out the concepts, design and manuscript preparation. FX, ZZ and HY carried out the cell experimental and analysis the date. XL, SW, JD, HC, JW and QW carried out the animal experimental and analysis the date. ZZ, JD and HC performed the manuscript review. All authors have read and approved the content of the manuscript.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This study was supported by National Natural Science Foundation of China (Grants&#x23;81801856), Natural Science Foundation of Jiangsu Province (Grants&#x23;BK20180949), Jiangsu Provincial Medical Youth Talent (Grants&#x23;QNRC2016343), Six Talent Peaks Project of Jiangsu Province (Grants&#x23;YY-221, XCL-063) and Key Medical Talent of Yangzhou Public Health Bureau (Grants&#x23;2018-6).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banaszynski</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.-c.</given-names>
</name>
<name>
<surname>Maynard-Smith</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>A. G. L.</given-names>
</name>
<name>
<surname>Wandless</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules</article-title>. <source>Cell</source> <volume>126</volume>, <fpage>995</fpage>&#x2013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.07.025</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boccaccini</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Blaker</surname>
<given-names>J.&#x20;J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Bioactive Composite Materials for Tissue Engineering Scaffolds</article-title>. <source>Expert Rev. Med. Devices</source> <volume>2</volume>, <fpage>303</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1586/17434440.2.3.303</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collignon</surname>
<given-names>A.-M.</given-names>
</name>
<name>
<surname>Lesieur</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vacher</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chaussain</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rochefort</surname>
<given-names>G. Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Strategies Developed to Induce, Direct, and Potentiate Bone Healing</article-title>. <source>Front. Physiol.</source> <volume>8</volume>, <fpage>927</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2017.00927</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xian</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Role of FGFs/FGFRs in Skeletal Development and Bone Regeneration</article-title>. <source>J.&#x20;Cel. Physiol.</source> <volume>227</volume>, <fpage>3731</fpage>&#x2013;<lpage>3743</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24083</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farokhi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mottaghitalab</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fatahi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Saeb</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Zarrintaj</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S. C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Silk Fibroin Scaffolds for Common Cartilage Injuries: Possibilities for Future Clinical Applications</article-title>. <source>Eur. Polym. J.</source> <volume>115</volume>, <fpage>251</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1016/j.eurpolymj.2019.03.035</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farokhi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mottaghitalab</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Ramakrishna</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Functionalized Silk Fibroin Nanofibers as Drug Carriers: Advantages and Challenges</article-title>. <source>J.&#x20;Controlled Release</source> <volume>321</volume>, <fpage>324</fpage>&#x2013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2020.02.022</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farokhi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mottaghitalab</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Samani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shokrgozar</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>R. L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Silk Fibroin/hydroxyapatite Composites for Bone Tissue Engineering</article-title>. <source>Biotechnol. Adv.</source> <volume>36</volume>, <fpage>68</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2017.10.001</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farokhi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mottaghitalab</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shokrgozar</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.-W.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Prospects of Peripheral Nerve Tissue Engineering Using Nerve Guide Conduits Based on Silk Fibroin Protein and Other Biopolymers</article-title>. <source>Int. Mater. Rev.</source> <volume>62</volume>, <fpage>367</fpage>&#x2013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1080/09506608.2016.1252551</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groeneveld</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Bone Morphogenetic Proteins in Human Bone Regeneration</article-title>. <source>Eur. J.&#x20;Endocrinol.</source> <volume>142</volume>, <fpage>9</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1530/eje.0.1420009</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Novel Hydroxyapatite/tussah Silk Fibroin/chitosan Bone-like Nanocomposites</article-title>. <source>Polym. Bull.</source> <volume>68</volume>, <fpage>1765</fpage>&#x2013;<lpage>1776</lpage>. <pub-id pub-id-type="doi">10.1007/s00289-012-0702-5</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Aoyama</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tamura</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Promoted Bone Healing at a Rabbit Skull Gap between Autologous Bone Fragment and the Surrounding Intact Bone with Biodegradable Microspheres Containing Transforming Growth Factor-&#x392;1</article-title>. <source>Tissue Eng.</source> <volume>6</volume>, <fpage>331</fpage>&#x2013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1089/107632700418056</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Lachaud</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Asatrian</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2</article-title>. <source>Tissue Eng. B: Rev.</source> <volume>22</volume>, <fpage>284</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2015.0357</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ko</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Electrospun Silk Fibroin Nanofibrous Scaffolds with Two-Stage Hydroxyapatite Functionalization for Enhancing the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells</article-title>. <source>ACS Appl. Mater. Inter.</source> <volume>10</volume>, <fpage>7614</fpage>&#x2013;<lpage>7625</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.7b03328</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jadlowiec</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Insulin-like Growth Factor-I Induces Early Osteoblast Gene Expression in Human Mesenchymal Stem Cells</article-title>. <source>Stem Cell Dev.</source> <volume>14</volume>, <fpage>621</fpage>&#x2013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2005.14.621</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayr-Wohlfart</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Waltenberger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hausser</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>G&#xfc;nther</surname>
<given-names>K.-P.</given-names>
</name>
<name>
<surname>Dehio</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Vascular Endothelial Growth Factor Stimulates Chemotactic Migration of Primary Human Osteoblasts</article-title>. <source>Bone</source> <volume>30</volume>, <fpage>472</fpage>&#x2013;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1016/s8756-3282(01)00690-1</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oikawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tada-Oikawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kawanishi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>N-acetylcysteine, a Cancer Chemopreventive Agent, Causes Oxidative Damage to Cellular and Isolated DNA</article-title>. <source>Carcinogenesis</source> <volume>20</volume>, <fpage>1485</fpage>&#x2013;<lpage>1490</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/20.8.1485</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ontoria</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Altamura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferrigno</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Laufer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Muraglia</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Identification of Novel, Selective, and Stable Inhibitors of Class II Histone Deacetylases. Validation Studies of the Inhibition of the Enzymatic Activity of HDAC4 by Small Molecules as a Novel Approach for Cancer Therapy</article-title>. <source>J.&#x20;Med. Chem.</source> <volume>52</volume>, <fpage>6782</fpage>&#x2013;<lpage>6789</lpage>. <pub-id pub-id-type="doi">10.1021/jm900555u</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mcclure</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Madurantakam</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Extracellular Matrix Regenerated: Tissue Engineering via Electrospun Biomimetic Nanofibers</article-title>. <source>Polym. Int.</source> <volume>56</volume>, <fpage>1349</fpage>&#x2013;<lpage>1360</lpage>. <pub-id pub-id-type="doi">10.1002/pi.2344</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trinca</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Westin</surname>
<given-names>C. B.</given-names>
</name>
<name>
<surname>Da Silva</surname>
<given-names>J.&#x20;A. F.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>&#xc2;. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Electrospun Multilayer Chitosan Scaffolds as Potential Wound Dressings for Skin Lesions</article-title>. <source>Eur. Polym. J.</source> <volume>88</volume>, <fpage>161</fpage>&#x2013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/j.eurpolymj.2017.01.021</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Niibe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Preconditioning of Bone Marrow-Derived Mesenchymal Stem Cells with N-Acetyl-L-Cysteine Enhances Bone Regeneration via Reinforced Resistance to Oxidative Stress</article-title>. <source>Biomaterials</source> <volume>185</volume>, <fpage>25</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.08.055</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A Chemical Approach to Stem-Cell Biology and Regenerative Medicine</article-title>. <source>Nature</source> <volume>453</volume>, <fpage>338</fpage>&#x2013;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1038/nature07042</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Electrospun Nanofibers: New Concepts, Materials, and Applications</article-title>. <source>Acc. Chem. Res.</source> <volume>50</volume>, <fpage>1976</fpage>&#x2013;<lpage>1987</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.7b00218</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsukimura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sugita</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Att</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>N-acetyl Cysteine as an Osteogenesis-Enhancing Molecule for Bone Regeneration</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>6147</fpage>&#x2013;<lpage>6156</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.04.064</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Antioxidative Fullerol Promotes Osteogenesis of Human Adipose-Derived Stem Cells</article-title>. <source>Int. J.&#x20;Nanomedicine.</source> <volume>9</volume>, <fpage>4023</fpage>&#x2013;<lpage>4031</lpage>. <pub-id pub-id-type="doi">10.2147/ijn.s66785</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zafarullah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W. Q.</given-names>
</name>
<name>
<surname>Sylvester</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Molecular Mechanisms of N -acetylcysteine Actions</article-title>. <source>Cell Mol. Life Sci. (Cmls)</source> <volume>60</volume>, <fpage>6</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1007/s000180300001</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Characterization and Antibacterial Activity of Amoxicillin-Loaded Electrospun Nano-Hydroxyapatite/poly(lactic-Co-Glycolic Acid) Composite Nanofibers</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>1402</fpage>&#x2013;<lpage>1412</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.10.071</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y.-x.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>J.-j.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.-y.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>S.-c.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>H.-c.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>N-acetyl Cysteine Protects Human Oral Keratinocytes from Bis-GMA-Induced Apoptosis and Cell Cycle Arrest by Inhibiting Reactive Oxygen Species-Mediated Mitochondrial Dysfunction and the PI3K/Akt Pathway</article-title>. <source>Toxicol. Vitro</source> <volume>29</volume>, <fpage>2089</fpage>&#x2013;<lpage>2101</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2015.09.002</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>NAC-loaded Electrospun Scaffolding System with Dual Compartments for the Osteogenesis of rBMSCs <italic>In Vitro</italic>
</article-title>. <source>Nt J.&#x20;Nanomedicine</source> <volume>14</volume>, <fpage>787</fpage>&#x2013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.2147/ijn.s183233</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>